Back
Warrior Met Coal Vs. Summit Therapeutics Industry Stock Comparison
Buy
62
HCC
Warrior Met Coal
Last Price:
64.40
Seasonality Move:
9.86%
Sell
46
SMMT
Summit Therapeutics
Last Price:
18.91
Seasonality Move:
25.3%
Buy
62
Warrior Met Coal (HCC)
is a Buy
Is Warrior Met Coal a Buy, Sell or Hold?
- The current Warrior Met Coal [HCC] share price is $63.93. The Score for HCC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- HCC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $19.09. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HCC Stock Price Chart
What is Warrior Met Coal's stock price today?
-
The Warrior Met Coal share price today is $63.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HCC is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $19.09
The current trend is moderately bearish and SMMT is experiencing slight selling pressure.
HCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 62.72 | Buy |
| Chaikin Money Flow: | 155275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.9 - 61.68) | Buy |
| Bollinger Bands (100): | (57.69 - 68.69) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -3703643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.77 - 26.29) | Sell |
| Bollinger Bands (100): | (5.55 - 18.21) | Buy |
HCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.75 | Buy |
| 20-day SMA: | 57.63 | Buy |
| 50-day SMA: | 59.32 | Buy |
| 200-day SMA: | 62.49 | Buy |
| 8-day EMA: | 62.03 | Buy |
| 20-day EMA: | 59.78 | Buy |
| 50-day EMA: | 60.03 | Buy |
| 200-day EMA: | 59.73 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.7 | Sell |
| 20-day SMA: | 23.17 | Sell |
| 50-day SMA: | 16.29 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 20.46 | Sell |
| 20-day EMA: | 20.64 | Sell |
| 50-day EMA: | 17.31 | Buy |
| 200-day EMA: | 9.71 | Buy |
Warrior Met Coal Earnings Growth & HCC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and an increase next year of $0.03 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and a decrease next year of $0.03 per share.
Warrior Met Coal Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||